Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
WuXi XDC Cayman, Inc. ( (HK:2268) ) just unveiled an announcement.
WuXi XDC Cayman Inc. has completed a connected transaction involving the subscription of new shares under a specific mandate. On October 22, 2025, WuXi Biologics successfully subscribed to 24,134,000 new shares at a price of HK$58.85 per share, resulting in net proceeds of approximately HK$1,414.47 million. This transaction has increased WuXi Biologics’ shareholding in the company from 49.75% to 50.72%, slightly altering the company’s shareholding structure.
The most recent analyst rating on (HK:2268) stock is a Hold with a HK$63.30 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
More about WuXi XDC Cayman, Inc.
Average Trading Volume: 7,718,994
Technical Sentiment Signal: Buy
Current Market Cap: HK$85.4B
Find detailed analytics on 2268 stock on TipRanks’ Stock Analysis page.